337.37
-24.39
(-6.74%)
As of 3:05:15 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 9 | 10 | 11 |
Avg. Estimate | 8.19 | 15.99 | 49.51 | 64.35 |
Low Estimate | 3.66 | 14.22 | 44.05 | 58 |
High Estimate | 11.07 | 17 | 56.25 | 73.25 |
Year Ago EPS | 16.32 | 16.85 | 29.83 | 49.51 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 4 | 6 |
Avg. Estimate | 3.86B | 4.09B | 16.12B | 17.16B |
Low Estimate | 3.78B | 4.05B | 15.82B | 16B |
High Estimate | 3.98B | 4.14B | 16.48B | 18.21B |
Year Ago Sales | 4.13B | 4.08B | 15.81B | 16.12B |
Sales Growth (year/est) | -6.49% | 0.09% | 1.91% | 6.50% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 16.03 | 16.64 | 11.73 | -17.42 |
EPS Actual | 16.32 | 16.85 | 14.62 | -18.39 |
Difference | 0.29 | 0.21 | 2.89 | -0.97 |
Surprise % | 1.83% | 1.26% | 24.63% | -5.56% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 8.19 | 15.99 | 49.51 | 64.35 |
7 Days Ago | 8.09 | 15.84 | 49.42 | 64.36 |
30 Days Ago | 8.11 | 15.84 | 49.45 | 64.37 |
60 Days Ago | 12.38 | 16.92 | 56.71 | 68.88 |
90 Days Ago | 18.03 | 17.93 | 65.81 | 73.84 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | 1 | 1 | -- |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 2 | 1 | 1 | 3 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EG | -49.82% | -5.11% | 65.99% | 29.95% |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Downgrade | Morgan Stanley: Overweight to Equal-Weight | 2/5/2025 |
Maintains | Barclays: Overweight to Overweight | 2/4/2025 |
Downgrade | BMO Capital: Outperform to Market Perform | 1/30/2025 |
Maintains | Barclays: Overweight to Overweight | 1/28/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/14/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/10/2025 |
Related Tickers
RNR RenaissanceRe Holdings Ltd.
233.63
-4.78%
RGA Reinsurance Group of America, Incorporated
171.46
-8.37%
SPNT SiriusPoint Ltd.
15.93
-9.31%
HG Hamilton Insurance Group, Ltd.
18.86
-10.50%
GLRE Greenlight Capital Re, Ltd.
12.80
-3.90%
HUW.L Helios Underwriting plc
192.50
-4.70%
SCRYY SCOR SE
2.7800
-4.47%
65C.DU Coface SA
17.26
-1.43%
RNR-PF RenaissanceRe Holdings Ltd.
21.41
+0.05%
SSREY Swiss Re AG
39.93
-8.15%